Business
Opthea Doses First Patient in OPT-302 wAMD Ph2b trial
Opthea Doses First Patient in OPT-302 wAMD Ph2b trial
About this update from Opthea Limited
[{"type":"text","content":"Opthea Ltd has released a press release. View Attachment","length":218,"tagName":"div"}]